中国抗癌协会神经内分泌肿瘤专业委员会. 中国抗癌协会神经内分泌肿瘤整合诊治指南(精简版)[J]. 中国肿瘤临床, 2023, 50(8): 385-397. DOI: 10.12354/j.issn.1000-8179.2023.20221522
引用本文: 中国抗癌协会神经内分泌肿瘤专业委员会. 中国抗癌协会神经内分泌肿瘤整合诊治指南(精简版)[J]. 中国肿瘤临床, 2023, 50(8): 385-397. DOI: 10.12354/j.issn.1000-8179.2023.20221522
China Anti-Cancer Association Committee of Neuroendocrine. China Anti-Cancer Association guideline for the diagnosis and treatment of neuroendocrine neoplasms (abridged version)[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 50(8): 385-397. DOI: 10.12354/j.issn.1000-8179.2023.20221522
Citation: China Anti-Cancer Association Committee of Neuroendocrine. China Anti-Cancer Association guideline for the diagnosis and treatment of neuroendocrine neoplasms (abridged version)[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 50(8): 385-397. DOI: 10.12354/j.issn.1000-8179.2023.20221522

中国抗癌协会神经内分泌肿瘤整合诊治指南(精简版)

China Anti-Cancer Association guideline for the diagnosis and treatment of neuroendocrine neoplasms (abridged version)

  • 摘要: 神经内分泌肿瘤(neuroendocrine neoplasms,NENs)是一类起源于肽能神经元和神经内分泌细胞,具有神经内分泌分化并表达神经内分泌标志物的少见肿瘤,可发生于全身各处,以肺及胃肠胰NEN(gastroentero-pancreatic neuroendocrine neoplasms,GEP-NENs)最常见。国内外研究数据提示,NENs的发病率在不断上升。美国流行病学调查结果显示,与其他类型肿瘤相比,NENs的发病率上升趋势更为显著。中国抗癌协会神经内分泌肿瘤专业委员会在现有循证医学证据基础上,结合已有国内外指南和共识,制订了首版中国抗癌协会神经内分泌肿瘤整合诊治指南,为临床工作者提供参考。

     

    Abstract: Neuroendocrine neoplasms (NENs) are a kind of rare tumors that originate from peptidergic neurons and neuroendocrine cells that show neuroendocrine differentiation and express neuroendocrine markers. NENs can occur in any part of the body; however, they are common in the lungs, stomach, intestines, and pancreas. National and international research data suggest a rise in the incidence of NENs. The results of epidemiological investigations from the United States have showed that, compared with other types of tumors, there was a more significant increase in the incidence of NENs. Based on existing evidence, in addition to national and international guidelines and consensus, the experts from China Anti-Cancer Association Committee of Neuroendocrine formulated its first guideline for the diagnosis and treatment of NENs to serve as a reference for clinical physicians.

     

/

返回文章
返回